Gavilax Powder, For Solution
NDC Package 43386-312-08
Package Information
Gavilax (polyethylene glycol 3350) powders is do not take more than directed unless advised by your doctorthe bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line.adults and children 17 years of age and older:use once a dayfill to top of line in cap which is marked to indicate the correct dose (17 g)stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drinkdo not combine with starch-based thickeners used for difficulty swallowingensure that the powder is fully dissolved before drinkingdo not drink if there are any clumpsdo not use more than 7 dayschildren 16 years of age or under: ask a doctorOther Information store at 20°- 25°C (68°– 77°F)tamper-evident: do not use if printed foil seal under cap, printed with "SEALED for YOUR PROTECTION" is missing, open or broken. This formulation utilizes a powder, for solution delivery system. Marketed by Lupin Pharmaceuticals,inc., this product is identified by NDC 43386-312 and is authorized under FDA application ANDA091077.
Identification & Billing
- RxCUI: 876193 - polyethylene glycol 3350 17 GM Powder for Oral Solution
- RxCUI: 876193 - polyethylene glycol 3350 17000 MG Powder for Oral Solution
- RxCUI: 876214 - GaviLAX 17 GM Powder for Oral Solution
- RxCUI: 876214 - polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax]
- RxCUI: 876214 - Gavilax 17 GM Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43386 - Lupin Pharmaceuticals,inc.
- 43386-312 - Gavilax
- 43386-312-08 - 238 g in 1 BOTTLE
- 43386-312 - Gavilax
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (43386-312). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43386-312-08 identifies a specific commercial package of 238 g in 1 bottle of Gavilax, a human over the counter drug labeled by Lupin Pharmaceuticals,inc.. This powder, for solution is formulated for oral use and contains polyethylene glycol 3350 as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lupin Pharmaceuticals,inc. on October 09, 2009. The current certification is valid through December 31, 2027.
How is this Lupin Pharmaceuticals,inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43386031208. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 238 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.